Oxford University Press (OUP) is pleased to announce the launch of Regenerative Biomaterials (RB), published in association with the Chinese Society for Biomaterials (CSBM).
Prof. Xingdong Zhang, President of CSBM and Editor-in-Chief of RB, said: "We are very delighted that the Chinese Society for Biomaterials finally has an official, international journal, through the joint efforts of the Society and Oxford University Press. Biomaterials, the rapid-growing high-tech materials, are necessities to safeguard people's health as pharmaceuticals do. While regenerative medicine has become a major component of modern medicine, biomaterials used for the regeneration and repair of tissues or organs have become a main direction for the development of the current biomaterials. Regenerative biomaterials, which could be interpreted as the biomaterials able to regenerate a living tissue or organ and thus permanently heal the damaged tissue or organ, are leading to a revolutionary change to contemporary biomaterials science and engineering and will promote the progress of modern medicine".
Regenerative Biomaterials aims to provide a leading international forum for the publication of original research papers, reviews, clinical case reports, and commentaries on the topics relevant to the development of advanced regenerative biomaterials. The journal will cover novel regenerative technologies and therapeutic approaches for the regeneration and repair of damaged tissues and organs.
Kimi Zeng, Assistant Consultant, Oxford University Press, commented: "Oxford University Press aims to work with the highest quality China-based English journals, to help Chinese authors publish in international journals, and to disseminate the best scholarship to the widest possible audience. We are excited about this promising new journal and this partnership will continue to strengthen the excellent science publishing programme at OUP".
RB gives preference to articles addressing biomaterials for communications among various disciplines involved with biomaterials, nanotechnologies, stem cell biology, regenerative medicine, and clinical medicine.
The journal will be officially launched in November 2014 and it will be open access online. Visit the website for more information, submission guidelines, and sign up to receive tables of contents by email or RSS: http://rb.